Head of Investor Relations
Charles River Laboratories International, Inc. (CRL)Equibles does not estimate personal net worth.
Get an email with a short summary when Charles River Laboratories International, Inc. publishes a filing, an earnings call transcript or a press release.
Get CRL alertsTodd Spencer is recorded as Head of Investor Relations at Charles River Laboratories International, Inc. (CRL). Todd Spencer has spoken on 24 earnings calls across 1 company, most recently for Charles River Laboratories International, Inc. on August 5, 2026. Charles River Laboratories International, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Charles River Laboratories International, Inc. includes Abraham Ceesay (CEO and Board Member), Craig B. Thompson (CEO and Board Member), James C. Foster (CEO and Board Member) and 7 others.
“Good morning, and welcome to Charles River Laboratory's second quarter 2026 earnings conference call and webcast. This morning, I am pleased to be joined by Birgit Gershik, our Chief Executive Officer, and by Glenn Coleman, our Executive Vice President and Chief Financial Officer.”
“Good morning and welcome to Charles River Laboratory's first quarter 2026 earnings conference call and webcast. This morning, I am pleased to be joined by Birgit Gershik, who became our Chief Executive Officer this week, and to introduce our new Executive Vice President and Chief Financial Officer, Glenn Coleman.”
“Good morning, and welcome to Charles River Laboratory's fourth quarter and full year 2025 earnings and 2026 guidance conference call and webcast.”
“Good morning, and welcome to Charles River Laboratories Third Quarter 2025 Earnings Conference Call and Webcast. This morning, I am joined by Jim Foster, Chair, President and Chief Executive Officer; and Mike Knell, Senior Vice President, Interim Chief Financial Officer and Chief Accounting Officer.”
“Good morning, and welcome to Charles River Laboratories Second Quarter 2025 Earnings Conference Call and Webcast. This morning, I am joined by Jim Foster, Chair, President and Chief Executive Officer; and Flavia Pease, Executive Vice President and Chief Financial Officer.”
Diagnostics & Research · Healthcare
Head of Investor Relations
